Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Hyperglycemia on Microvascular Perfusion in Healthy Adults
NCT03520569Phase 1Completed
- Sponsor
- University of Virginia
- Start
- Feb 2019
- Primary completion
- Apr 2021
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial (4 arms), sponsored by University of Virginia. Primary endpoint: Flow Mediated Dilation at 2 hours. Started Feb 2019; status: completed.
Beyond the preview
Go deeper on NCT03520569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03520569.